Skip to main content

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM BSE: 507789Pharma

Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]

201
52W: ₹155 — ₹302
PE 30.1 · Book ₹41.2 · +388% vs book
Market Cap₹1,346 Cr
Stock P/E30.1Price to Earnings
ROCE22.7%Return on Capital
ROE17.3%Return on Equity
Div. Yield1.23%Face Value ₹2

Strengths

  • +Company is almost debt free.
  • +Company has been maintaining a healthy dividend payout of 50.3%
  • +Company's working capital requirements have reduced from 24.0 days to 11.0 days

Weaknesses

  • The company has delivered a poor sales growth of 8.85% over past five years.

Shareholding Pattern

Promoters67.89%
FIIs2.44%
DIIs0.22%
Public29.44%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters68.04%67.98%0.167.82%0.267.77%0.067.65%0.167.54%0.167.39%0.267.89%0.5
FIIs1.1%2.3%1.22.1%0.22.1%2.17%0.12.12%0.02.12%2.44%0.3
DIIs0.84%0.11%0.70%0.10%0.05%0.10.08%0.00.15%0.10.22%0.1
Public30.01%29.63%0.430.1%0.530.11%0.030.12%0.030.25%0.130.34%0.129.44%0.9

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales47.2343.4961.4474.6974.0358.5675.6174.4772.9564.2
Expenses43.8340.8251.1958.458.1949.8561.4158.0356.6853.04
Operating Profit3.42.6710.2516.2915.848.7114.216.4416.2711.16
OPM %7.2%6.14%16.68%21.81%21.4%14.87%18.78%22.08%22.3%17.38%
Net Profit3.963.555.3311.4631.996.5810.812.5710.958.76
EPS ₹0.60.540.811.734.820.991.621.891.641.31

AI Insights

Revenue Trend

Mar 2026 revenue at ₹287Cr, up 6.7% YoY. OPM at 20%.

Debt Position

Borrowings at ₹8Cr. Debt-to-equity ratio: 0.03x. Healthy balance sheet.

Institutional Flow

DIIs: 0.22% (-0.60pp change). FIIs: 2.44% (+2.07pp change). Promoters hold 67.89%.

Margin & Efficiency

ROCE improving from 5% (Mar 2015) to 23% (Mar 2026). Working capital days: 11.

Valuation

PE 30.1x with 22.7% ROCE. Price is 388% above book value of ₹41.2. Dividend yield: 1.23%.

Recent Announcements